The global market for Human Microbiome Therapeutics was valued at US$ 1113 million in the year 2024 and is projected to reach a revised size of US$ 1806 million by 2031, growing at a CAGR of 7.3% during the forecast period.

Human Microbiome Therapeutics Market

Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Microbiome therapeutics are therapies that are designed to disrupt unhealthy microbial ecological networks and that catalyse the establishment of healthy ones.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Human Microbiome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Therapeutics.

The Human Microbiome Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Microbiome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Microbiome Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Human Microbiome Therapeutics Market Report

Report Metric	Details
Report Name	Human Microbiome Therapeutics Market
Accounted market size in year	US$ 1113 million
Forecasted market size in 2031	US$ 1806 million
CAGR	7.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	FMT Microbiome Drugs
Segment by Application	C. difficile Crohn’s Disease Inflammatory Bowel Disease Diabetes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Enterome Bioscience, Rebiotix, Seres Therapeutics, Vedanta Biosciences, Bristol-Myers Squibb, Johnson & Johnson, Takeda Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Human Microbiome Therapeutics Market growing?

Ans: The Human Microbiome Therapeutics Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the Human Microbiome Therapeutics Market size in 2031?

Ans: The Human Microbiome Therapeutics Market size in 2031 will be US$ 1806 million.

Who are the main players in the Human Microbiome Therapeutics Market report?

Ans: The main players in the Human Microbiome Therapeutics Market are Enterome Bioscience, Rebiotix, Seres Therapeutics, Vedanta Biosciences, Bristol-Myers Squibb, Johnson & Johnson, Takeda Pharmaceutical

What are the Application segmentation covered in the Human Microbiome Therapeutics Market report?

Ans: The Applications covered in the Human Microbiome Therapeutics Market report are C. difficile, Crohn’s Disease, Inflammatory Bowel Disease, Diabetes, Others

What are the Type segmentation covered in the Human Microbiome Therapeutics Market report?

Ans: The Types covered in the Human Microbiome Therapeutics Market report are FMT, Microbiome Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 FMT

1.2.3 Microbiome Drugs

1.3 Market by Application

1.3.1 Global Human Microbiome Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 C. difficile

1.3.3 Crohn’s Disease

1.3.4 Inflammatory Bowel Disease

1.3.5 Diabetes

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Microbiome Therapeutics Market Perspective (2020-2031)

2.2 Global Human Microbiome Therapeutics Growth Trends by Region

2.2.1 Global Human Microbiome Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Human Microbiome Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Human Microbiome Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Human Microbiome Therapeutics Market Dynamics

2.3.1 Human Microbiome Therapeutics Industry Trends

2.3.2 Human Microbiome Therapeutics Market Drivers

2.3.3 Human Microbiome Therapeutics Market Challenges

2.3.4 Human Microbiome Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Microbiome Therapeutics Players by Revenue

3.1.1 Global Top Human Microbiome Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Human Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Human Microbiome Therapeutics Revenue

3.4 Global Human Microbiome Therapeutics Market Concentration Ratio

3.4.1 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutics Revenue in 2024

3.5 Global Key Players of Human Microbiome Therapeutics Head office and Area Served

3.6 Global Key Players of Human Microbiome Therapeutics, Product and Application

3.7 Global Key Players of Human Microbiome Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Human Microbiome Therapeutics Breakdown Data by Type

4.1 Global Human Microbiome Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Human Microbiome Therapeutics Forecasted Market Size by Type (2026-2031)

5 Human Microbiome Therapeutics Breakdown Data by Application

5.1 Global Human Microbiome Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Human Microbiome Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Human Microbiome Therapeutics Market Size (2020-2031)

6.2 North America Human Microbiome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Human Microbiome Therapeutics Market Size by Country (2020-2025)

6.4 North America Human Microbiome Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Microbiome Therapeutics Market Size (2020-2031)

7.2 Europe Human Microbiome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Human Microbiome Therapeutics Market Size by Country (2020-2025)

7.4 Europe Human Microbiome Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Human Microbiome Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Human Microbiome Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Human Microbiome Therapeutics Market Size (2020-2031)

9.2 Latin America Human Microbiome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Human Microbiome Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Human Microbiome Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Microbiome Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Human Microbiome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Enterome Bioscience

11.1.1 Enterome Bioscience Company Details

11.1.2 Enterome Bioscience Business Overview

11.1.3 Enterome Bioscience Human Microbiome Therapeutics Introduction

11.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2020-2025)

11.1.5 Enterome Bioscience Recent Development

11.2 Rebiotix

11.2.1 Rebiotix Company Details

11.2.2 Rebiotix Business Overview

11.2.3 Rebiotix Human Microbiome Therapeutics Introduction

11.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2020-2025)

11.2.5 Rebiotix Recent Development

11.3 Seres Therapeutics

11.3.1 Seres Therapeutics Company Details

11.3.2 Seres Therapeutics Business Overview

11.3.3 Seres Therapeutics Human Microbiome Therapeutics Introduction

11.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2020-2025)

11.3.5 Seres Therapeutics Recent Development

11.4 Vedanta Biosciences

11.4.1 Vedanta Biosciences Company Details

11.4.2 Vedanta Biosciences Business Overview

11.4.3 Vedanta Biosciences Human Microbiome Therapeutics Introduction

11.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2020-2025)

11.4.5 Vedanta Biosciences Recent Development

11.5 Bristol-Myers Squibb

11.5.1 Bristol-Myers Squibb Company Details

11.5.2 Bristol-Myers Squibb Business Overview

11.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Introduction

11.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2020-2025)

11.5.5 Bristol-Myers Squibb Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Human Microbiome Therapeutics Introduction

11.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2020-2025)

11.6.5 Johnson & Johnson Recent Development

11.7 Takeda Pharmaceutical

11.7.1 Takeda Pharmaceutical Company Details

11.7.2 Takeda Pharmaceutical Business Overview

11.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Introduction

11.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2020-2025)

11.7.5 Takeda Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical

List of Tables

Table 1. Global Human Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of FMT

Table 3. Key Players of Microbiome Drugs

Table 4. Global Human Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Human Microbiome Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Human Microbiome Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Human Microbiome Therapeutics Market Share by Region (2020-2025)

Table 8. Global Human Microbiome Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Human Microbiome Therapeutics Market Share by Region (2026-2031)

Table 10. Human Microbiome Therapeutics Market Trends

Table 11. Human Microbiome Therapeutics Market Drivers

Table 12. Human Microbiome Therapeutics Market Challenges

Table 13. Human Microbiome Therapeutics Market Restraints

Table 14. Global Human Microbiome Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Human Microbiome Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutics as of 2024)

Table 17. Ranking of Global Top Human Microbiome Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Human Microbiome Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Human Microbiome Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Human Microbiome Therapeutics, Product and Application

Table 21. Global Key Players of Human Microbiome Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Human Microbiome Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Human Microbiome Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Human Microbiome Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Human Microbiome Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Human Microbiome Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Human Microbiome Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Human Microbiome Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Human Microbiome Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Human Microbiome Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Human Microbiome Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Human Microbiome Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Human Microbiome Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Human Microbiome Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Human Microbiome Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Human Microbiome Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Enterome Bioscience Company Details

Table 47. Enterome Bioscience Business Overview

Table 48. Enterome Bioscience Human Microbiome Therapeutics Product

Table 49. Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Enterome Bioscience Recent Development

Table 51. Rebiotix Company Details

Table 52. Rebiotix Business Overview

Table 53. Rebiotix Human Microbiome Therapeutics Product

Table 54. Rebiotix Revenue in Human Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Rebiotix Recent Development

Table 56. Seres Therapeutics Company Details

Table 57. Seres Therapeutics Business Overview

Table 58. Seres Therapeutics Human Microbiome Therapeutics Product

Table 59. Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Seres Therapeutics Recent Development

Table 61. Vedanta Biosciences Company Details

Table 62. Vedanta Biosciences Business Overview

Table 63. Vedanta Biosciences Human Microbiome Therapeutics Product

Table 64. Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Vedanta Biosciences Recent Development

Table 66. Bristol-Myers Squibb Company Details

Table 67. Bristol-Myers Squibb Business Overview

Table 68. Bristol-Myers Squibb Human Microbiome Therapeutics Product

Table 69. Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Bristol-Myers Squibb Recent Development

Table 71. Johnson & Johnson Company Details

Table 72. Johnson & Johnson Business Overview

Table 73. Johnson & Johnson Human Microbiome Therapeutics Product

Table 74. Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Johnson & Johnson Recent Development

Table 76. Takeda Pharmaceutical Company Details

Table 77. Takeda Pharmaceutical Business Overview

Table 78. Takeda Pharmaceutical Human Microbiome Therapeutics Product

Table 79. Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Takeda Pharmaceutical Recent Development

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

Table 84. Authors List of This Report

List of Figures

Figure 1. Human Microbiome Therapeutics Picture

Figure 2. Global Human Microbiome Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Microbiome Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. FMT Features

Figure 5. Microbiome Drugs Features

Figure 6. Global Human Microbiome Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Human Microbiome Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. C. difficile Case Studies

Figure 9. Crohn’s Disease Case Studies

Figure 10. Inflammatory Bowel Disease Case Studies

Figure 11. Diabetes Case Studies

Figure 12. Others Case Studies

Figure 13. Human Microbiome Therapeutics Report Years Considered

Figure 14. Global Human Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Human Microbiome Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Human Microbiome Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Human Microbiome Therapeutics Market Share by Players in 2024

Figure 18. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Human Microbiome Therapeutics Revenue in 2024

Figure 20. North America Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Human Microbiome Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Human Microbiome Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Human Microbiome Therapeutics Market Share by Region (2020-2031)

Figure 34. China Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Human Microbiome Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Human Microbiome Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Human Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Enterome Bioscience Revenue Growth Rate in Human Microbiome Therapeutics Business (2020-2025)

Figure 50. Rebiotix Revenue Growth Rate in Human Microbiome Therapeutics Business (2020-2025)

Figure 51. Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutics Business (2020-2025)

Figure 52. Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutics Business (2020-2025)

Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutics Business (2020-2025)

Figure 54. Johnson & Johnson Revenue Growth Rate in Human Microbiome Therapeutics Business (2020-2025)

Figure 55. Takeda Pharmaceutical Revenue Growth Rate in Human Microbiome Therapeutics Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions